IKARIAN CAPITAL, LLC – Neurocrine Biosciences, Inc. Transaction History
IKARIAN CAPITAL, LLC portfolio value:
$0
portfolio value
IKARIAN CAPITAL, LLC quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -38.6K shares | -3.76M | $106.21 | 0 |
| Q2 2022 | share | Increase | 0.00% | 38.6K shares | 3.76M | $97.48 | 38.6K |
| Q2 2022 | call | Decrease | -100.00% | -429.6K shares | -40.27M | $97.48 | 0 |
| Q1 2022 | call | Increase | 0.00% | 429.6K shares | 40.27M | $93.75 | 429.6K |
| Q1 2021 | call | Decrease | -100.00% | -23.7K shares | -2.27M | $97.25 | 0 |
| Q4 2020 | call | Increase | 0.00% | 23.7K shares | 2.27M | $95.85 | 23.7K |
| Q2 2020 | call | Decrease | -100.00% | -100K shares | -8.65M | $122 | 0 |
| Q1 2020 | call | Increase | +1288.89% | 92.8K shares | 7.88M | $86.55 | 100K |
| Q4 2019 | call | Increase | 0.00% | 7.2K shares | 774K | $107.49 | 7.2K |